↓ Skip to main content

Dove Medical Press

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study

Overview of attention for article published in Journal of Asthma and Allergy, February 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
40 Mendeley
Title
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
Published in
Journal of Asthma and Allergy, February 2021
DOI 10.2147/jaa.s288260
Pubmed ID
Authors

Claire Emson, Jonathan Corren, Kinga Sałapa, Åsa Hellqvist, Jane R Parnes, Gene Colice

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 15%
Other 2 5%
Student > Ph. D. Student 2 5%
Student > Master 2 5%
Professor 2 5%
Other 4 10%
Unknown 22 55%
Readers by discipline Count As %
Medicine and Dentistry 11 28%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Social Sciences 1 3%
Engineering 1 3%
Other 0 0%
Unknown 24 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2023.
All research outputs
#15,705,694
of 24,880,704 outputs
Outputs from Journal of Asthma and Allergy
#313
of 527 outputs
Outputs of similar age
#284,115
of 518,551 outputs
Outputs of similar age from Journal of Asthma and Allergy
#13
of 23 outputs
Altmetric has tracked 24,880,704 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 527 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,551 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.